December 20, 2014


HELP DEFEAT THE NUMBER ONE CANCER IN MEN

prostate cancer research fund

The Patrick C.Walsh
Prostate Cancer
Research Fund



Groundbreaking Developments
in Prostate Cancer at Johns Hopkins

Nerve-sparing radical prostatectomy

Definition of hereditary prostate cancer and cloning of prostate cancer genes

Identification of the most common genetic defect in prostate cancer (GSTP1)

Identification of a new concept in how cancer develops—inflammation

Identification of new markers of prostate cancer, e.g. AMACR

Design of gene therapy and prostate targeted therapy

Characterization of longitudinal changes in PSA(PSA velocity)

Predicting progression using PSA doubling time

Design and application of the Partin Tablesfor predicting the severity of prostate cancer

Staging of prostate cancer

The Battle Ahead
Targets for Discovery

Cause and prevention

Solving the mystery of hereditary disease

Improved diagnostics

Curative treatments with reduced side effects

Conquering advanced cancer



We are at War

The Brady Urological Institute is single-minded in its focus to eliminate the scourge of prostate cancer.

This full-scale assault hinges on strong collaboration among urologists, basic scientists, medical and radiation oncologists and pathologists. Our goal is to recruit every talented scientist at Johns Hopkins to join in this effort to conquer prostate cancer.

Over the past 20 years, progress in discovery has skyrocketed. Today, we are on the verge of a major breakthrough in understanding what causes prostate cancer, a discovery that will have a profound impact on approaches to prevention and treatment.

At no time in history has there been a greater opportunity to cure prostate cancer and prevent future generations of our sons and grandsons from developing the disease.

But Wars are Expensive

In our war against prostate cancer, we are pushing back the enemy's front lines, and changing the course of this disease. But wars are expensive. Fortunately, because of private gifts, we have been able to make progress faster than we ever could alone.

Patrick C. Walsh, M.D., has always believed that the best way to tackle the multifaceted problem of prostate cancer is to hit it hard from every possible angle and to support those scientists who are in the trenches leading the fight.

In recognition of this winning philosophy-and to make certain that Dr. Walsh's vision continues-Johns Hopkins has established The Patrick C. Walsh Prostate Cancer Research Fund.


Killer Facts

Prostate cancer is a formidable enemy. It kills fathers and grandfathers, sons and brothers. Worse, it is on the rise.

The disease is also much too common. This year alone, an estimated 210,000 American men will be diagnosed with prostate cancer, and 29,000 will die from it.

We find these numbers unacceptable.

The number of new cases of prostate cancer will double and possibly triple unless we find some way to prevent this disease.

Projected New Cases of Prostate Cancer

100,000 men will die unless we find new ways to cure prostate cancer.

Historical and Projected Deaths of Prostate Cancer


Data from Chan, J. (unpublished)


How You Can Join the Fight

The Patrick C. Walsh Prostate Cancer Research Fund will make it possible to attract and recruit the brightest scientists from all disciplines at Johns Hopkins to join our fight against prostate cancer.

Requests for research proposals will be distributed each year to scientists throughout Johns Hopkins. A scientific advisory board will award funding to projects holding the most promise.

The Walsh Fund has two components:

An endowed fund for current research initiatives, fellows and other research personnel.

A current use fund for new research initiatives, equipment and laboratory expansion.

We invite you to participate in this initiative to honor Dr. Walsh, and to further Hopkins’ effort to defeat prostate cancer.

NAMING       OPPORTUNITIES

$500,000 or more Donors who give $500,000 or more will be recognized as Founders’ Circle members on the masthead of the Brady Urological Institute’s annual letter and invited to an annual program with scientists who were awarded funding.

$1,000,000 or more Donors who give $1,000,000 or more will be members of the Founders’ Circle and have the opportunity to create a Named Scholar award. These donors will build a relationship with a scientist pursuing prostate cancer research and have their names cited in the scientist’s published research articles.



Johns Hopkins and the Brady
The Best of the Best

For 13 years, U.S. News & World Report’s annual ranking of American hospitals places The Johns Hopkins Hospital and The Brady Urological Institute No. 1 in the nation.

For 10 years, the National Institutes of Health ranks The Johns Hopkins University School of Medicine as the top recipient of federal research dollars.

Johns Hopkins Medicine and The Brady Urological Institute bring together the best and brightest minds in ground-breaking research and compassionate treatment of prostate cancer.


By supporting The Patrick C. Walsh Prostate Cancer
Research Fund, you assure the best of the best will
continue the fight until prostate cancer is defeated.
For more information on The Patrick C. Walsh
Prostate Cancer Research Fund, please call
the Brady Development office: 410-516-6160


THE BRADY UROLOGICAL INSTITUTE

 

© Copyright 2014 | All Rights Reserved | Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287